Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity
NCT04340752Phase 1Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of indocyanine green in rotator cuff tear (3 arms), sponsored by NYU Langone Health. Primary endpoint: Surgeon's ability to assess vascularity within the rotator cuff. Started Jan 2021; status: completed.
02
Drugs
indocyanine green
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT04340752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04340752.